Chronic Myelomonocytic Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
D
Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Boston, Massachusetts
  • +1 more
2022-01-12
Jan 12, 2022
H
Active, not recruiting
  • Myelodysplastic Syndrome
  • +3 more
  • Tampa, Florida
  • +5 more
2022-01-03
Jan 3, 2022
B
Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Los Angeles, California
  • +4 more
2022-01-11
Jan 11, 2022
F
Suspended
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-16
Dec 16, 2021
U
Active, not recruiting
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • Rochester, New York
    University of Rochester
2022-01-04
Jan 4, 2022
F
Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-01-03
Jan 3, 2022
M
Completed
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
2021-12-07
Dec 7, 2021
K
Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • DSP107
  • +2 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center, Department of
2021-12-31
Dec 31, 2021
N
Suspended
  • Acute Myeloid Leukemia
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center LAO
2021-12-29
Dec 29, 2021
M
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-28
Dec 28, 2021
P
Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Port Jefferson Station, New York
  • +1 more
2021-12-23
Dec 23, 2021
A
Not yet recruiting
  • Severe/Moderate Coronavirus
  • +3 more
  • Blood samples
  • Villejuif, France
    Gustave Roussy Institut
2021-12-20
Dec 20, 2021
M
Recruiting
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-21
Dec 21, 2021
A
Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +22 more
2021-12-05
Dec 5, 2021
M
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
2021-12-17
Dec 17, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
2021-12-06
Dec 6, 2021
M
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-01
Dec 1, 2021
J
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +24 more
2021-12-02
Dec 2, 2021
N
Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
2021-11-30
Nov 30, 2021
N
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
2021-11-30
Nov 30, 2021
M
Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-22
Nov 22, 2021
R
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-11-16
Nov 16, 2021